Frederik Rombouts

Vice President, Head of Drug Discovery, Augustine Therapeutics

Antwerp Metropolitan Area

About

Drug discovery leader with track record in: • Corporate and start-up biotech environments • Medicinal chemistry, drug clinical candidate and PET tracer discovery • Neuroscience and Oncology therapeutic area • People leadership, coaching, mentoring, development • Project leadership, matrix leadership, leading cross-functional teams • Academic & pharma partnerships • Due diligence, investor relations, grant funding • Challenging targets including protein-protein interactions, enzymes, proteases, allosteric mechanisms • Antibody-drug conjugates • Artificial Intelligence and Machine Learning applied to drug discovery • Working with CRO's worldwide • IP protection and patent writing

Experience

  • Augustine Therapeutics (Leuven, Flemish Region, Belgium)
    • Vice President, Drug Discovery
      Apr 2024 - Present · 2 yrs 4 mos

      Responsible for the small molecule drug pipeline of Augustine Therapeutics

    • Head of Medicinal Chemistry
      Jun 2022 - Apr 2024 · 1 yr 11 mos

      Responsible for the Augustine Tx portfolio, including medicinal chemistry and preclinical development.

  • The Janssen Pharmaceutical Companies of Johnson & Johnson (18 yrs 7 mos)
    • Senior Principal Scientist
      May 2019 - Jun 2022 · 3 yrs 2 mos

      Team leader and project leader in the Medicinal Chemistry Department with Neuroscience and Oncology focus.

    • Principal Scientist
      Apr 2013 - Apr 2019 · 6 yrs 1 mo

    • Senior Scientist
      May 2005 - Mar 2013 · 7 yrs 11 mos

      Team leader of Belgium-based Hit Generation Team in the Neuroscience Medicinal Chemistry Department. Responsible for generating high quality, IP free chemical starting points for projects and driving innovation within the Neuroscience portfolio.